Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STEP-ED: Reducing Duration of Untreated Psychosis and Its Impact in the U.S.

NCT02069925 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT02069925
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02069925 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STEP-ED: Reducing Duration of Untreated Psychosis and Its Impact in the U.S.
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2014
Completion date
August 18, 2020
Enrollment
285 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

psychosis, schizophrenia